Cancer Cell International invites you to join our team of reviewers. For consideration, please send your CV to michael.baden-campbell@biomedcentral.com.
New reviewer recruitment
Aims and scope
Cancer Cell International publishes articles on all aspects of cancer cell biology, originating largely from, but not limited to, work using cell culture techniques. Read more here.
Articles
-
-
Establishment and characterization of patient-derived cancer models of malignant peripheral nerve sheath tumors
-
Hsa_circ_0003159 inhibits gastric cancer progression by regulating miR-223-3p/NDRG1 axis
-
Caveolin-2 is regulated by BRD4 and contributes to cell growth in pancreatic cancer
-
Long noncoding RNA DANCR knockdown inhibits proliferation, migration and invasion of glioma by regulating miR-135a-5p/BMI1
-
Role of stem cells in cancer therapy and cancer stem cells: a review
-
Acidic extracellular microenvironment and cancer
-
Understanding the colon cancer stem cells and perspectives on treatment
-
B7-H3 promotes aggression and invasion of hepatocellular carcinoma by targeting epithelial-to-mesenchymal transition via JAK2/STAT3/Slug signaling pathway
-
Treatment with the PARP inhibitor, niraparib, sensitizes colorectal cancer cell lines to irinotecan regardless of MSI/MSS status
Trending articles
Click here to view which articles have been shared the most in the last month!
Editor-in-Chief
Domenico Coppola, Moffitt Cancer Center and Florida Digestive Health Specialists, USA
© Chee-Onn Leong
New thematic series: Circular RNA in cancer
Potential topics of interest include but are not limited to:
- The role of circRNAs in cancer initiation and progression;
- The potential of circRNAs as biomarkers for cancer diagnosis and/or prognosis;
- The potential of circRNAs as therapeutic targets for cancer.
The submission deadline for the series is May 31st, 2020. Submissions can be made through the journal's Editorial Manager system.
Spotlight: Associate Editor
Matteo Fassan
Matteo Fassan is Associate Professor of Pathology in the Department of Medicine at the University of Padua. He is a cancer researcher with expertise in the study of molecular pathology of non-neoplastic, pre-neoplastic, and neoplastic lesions of the gastrointestinal tract.
Spotlight: Editorial Board
Sritama Nath
Sritama Nath is a Medical Writer at MedThink Communications, a medical communications agency, where she develops scientific content for promotional medical education. She has several years of pre-clinical and clinical research experience in Oncology. She received her doctoral degree from UNC Charlotte and pursed postdoctoral trainings at University of Michigan at Ann Arbor and Duke University. Her research was focused on understanding the role of Mucin1 and XIAP proteins in induction of multi-drug resistance and resistance to immunotherapies in pancreatic and inflammatory breast cancers.
Advertisement
Follow
Annual Journal Metrics
-
Speed
56 days to first decision for reviewed manuscripts only
50 days to first decision for all manuscripts
114 days from submission to acceptance
12 days from acceptance to publicationCitation Impact
3.439 - 2-year Impact Factor
3.618 - 5-year Impact Factor
1.005 - Source Normalized Impact per Paper (SNIP)
1.180 - SCImago Journal Rank (SJR)Usage
385,203 Downloads
153 Altmetric mentions
On the blog
-
Looking beyond physical health for World Cancer Day 2020
24 January 2020
-
Breast Cancer Quiz 2019
30 September 2019
-
Sharing data for the benefit of children with cancer
09 September 2019
Institutional membership
Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).
Funding your APC
Advertisement
